ALPHA-DELTA-UA-[1->4]-GLCNAC(136098-07-2)
- Name: ALPHA-DELTA-UA-[1->4]-GLCNAC
- Synonyms:ALPHA-DELTA-UA-[1->4]-GLCNAC;HEPARIN DISACCHARIDE IV-A SODIUM SALT;DISACCHARIDE IV-A;DISACCHARIDE DELTA DI-HA;DELTAUA->GLCNAC NA;HEPARIN DISACCHARIDE IV-A SODIUM;(α-△ua-[1→4]-glcnac)
- Molecular Formula:C14H20NNaO11
- Molecular Weight:401.3
- CAS Registry Number:136098-07-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.136098-07-2 ALPHA-DELTA-UA-[1->4]-GLCNAC
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.136098-07-2 ALPHA-DELTA-UA-[1->4]-GLCNAC
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] CAS No.136098-07-2 Heparin disaccharide IV-A Sodium Salt
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.136098-07-2 Heparin disaccharide IV-A, sodium salt
Assay:鈮?0% Appearance:White to Brown Powder Storage:Store at -20掳C Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 134068-85-2/1H-Benzimidazole,2-methyl-4-(1-methylethyl)-(9CI)
- 134071-10-6/1H-Imidazolium, 1,3-bis[2-(2,4-dichlorophenyl)-2-oxoethyl]-, chloride (9CI)
- 134074-64-9/Oxpoconazole
- 134076-61-2/3-Chloro-6-methyl-6,7-dihydro-9H-5-oxa-9-azabenzocyclohepten-8-one
- 134076-69-0/2-Methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-7-carboxylic acid
- 134076-85-0/1,5-Benzoxazepine-4(5H)-thione, 2,3-dihydro-2,5-dimethyl-
- 134078-61-8/Carbamic acid, 2,4-pentadienyl-, 1,1-dimethylethyl ester, (Z)- (9CI)
- 134078-73-2/Carbamic acid, 1,3-pentadienyl-, 1,1-dimethylethyl ester, (E,Z)- (9CI)
- 134079-38-2/Pyrazine, 5-ethyl-3-methoxy-2-methyl- (9CI)
- 134096-16-5/Ethanol, 2, 2′,2′′-nitrilotris-, compd. With alpha-actadecyl-omega-hydroxypoly(oxy-1,2-ethanediyl) ester with 2-hydroxy- 1,2-3-propanetricarboxylic, EO 15-35 mol
- 134098-41-2/1,2-Cyclopropanedicarboxylicacid,1-amino-,trans-(9CI)
- 134098-72-9/2(3H)-Benzothiazolone,7-nitro-(9CI)
- 134099-28-8/3,4-DIFLUORO-5-(TRIFLUOROMETHYL)BENZALDEHYDE
- 134100-29-1/6-ACETAMIDO-6-DEOXY-CASTANOSPERMINE
- 134101-50-1/2-Naphthalenecarboxylicacid,1,2,3,4-tetrahydro-6,7-dihydroxy-(9CI)
- 134107-65-6/[S]-3-Phenyl-1,7a-dihydro-pyrrolo[1,2-c]oxazol-5-one
- 134134-88-6/Tetradecanoic acid, 2-decyltetradecyl ester
- 134135-41-4/5-(BROMOMETHYL)THIOPHENE-2-CARBONITRILE
- 134136-03-1/6-Benzothiazolecarboxylicacid,2-amino-4,5,6,7-tetrahydro-(9CI)
- 136098-07-2/ALPHA-DELTA-UA-[1->4]-GLCNAC
- 631858-22-5/Piperazine, 1-ethyl-4-(2-pyridinylmethyl)- (9CI)
- 134108-68-2/(1S,2S)-2-METHOXYCYCLOHEXANOL, CHIPROS\(TM, 99% EE 98
- 134108-92-2/(1S,2S)-(+)-2-Methoxycyclohexanol
- 134111-22-1/Oxiranemethanol,alpha,3-bis(1-methylethyl)-,[2alpha(R*),3bta]-(9CI)
- 134111-63-0/Cyclobutanecarboxylic acid, 3-ethylidene-2-methyl-, methyl ester, [1S-
- 134122-79-5/Galactitol, 1,4-anhydro-5-O-methyl-
- 134122-80-8/D-Galactofuranoside-6-C-d, methyl 3,5-di-O-methyl-, diacetate
- 134122-96-6/2-Naphthalenecarboxylic acid, 3,4-dihydro-6,7-dihydroxy- (9CI)
- 134124-34-8/Glycine, N-[(ethylamino)thioxomethyl]- (9CI)
- 134130-24-8/1,1,1-Tris(4-trifluorovinyloxyphenyl)ethane